COMP <GO>
BBNX vs IART // EV/EBITDA & P/E VALUATION
Beta Bionics Inc. (NASDAQ) VS. Integra LifeSciences Holdings Corporation (NASDAQ) • 15-METRIC TALLY: BBNX 4
— IART 5
■ METRIC PARITY
LAST: $17.58 (-1.51%) • MKT CAP: $955.8M
valuation
—
LAST: $12.83 (+4.82%) • MKT CAP: $998.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBNX VS. IART)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBNX | IART | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.40% | 50.90% | +4.50 | BBNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.10% | -35.00% | +12.90 | BBNX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.88% | -3.11% | -2.77 | IART | /fcf-yield <GO> |
| Operating Margin | -60.00% | -30.20% | -29.80 | IART | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -31.60% | -28.40 | IART | /net-margins <GO> |
| Revenue Growth (YoY) | 53.90% | 1.50% | +52.40 | BBNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.82 | 0.64 | +12.18 | BBNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 42.8 | -1.31 | IART | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $955.8M | $998.2M | -$42.4M | IART | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBNX REV | IART REV | BBNX GROSS % | IART GROSS % | BBNX FCF | IART FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.3M | $1.64B | 55.4% | 50.9% | -$56.2M | -$31.1M |
| FY 2024 | $65.1M | $1.61B | 55.1% | 54.8% | -$51.7M | $25.0M |
| FY 2023 | $12.0M | $1.54B | — | — | -$32.4M | $140.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBNX // BETA —
IART // BETA —